Tamminga, Cindy <br/><br/>
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  Oct 2013 
 - 2165-77 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.4161/hv.24941  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviruses, Human--genetics<br/>Adolescent<br/>Adult<br/>Antibodies, Protozoan--blood<br/>Antigens, Protozoan--genetics<br/>Enzyme-Linked Immunosorbent Assay<br/>Enzyme-Linked Immunospot Assay<br/>Female<br/>Genetic Vectors<br/>Humans<br/>Injections, Intramuscular<br/>Interferon-gamma--metabolism<br/>Leukocytes, Mononuclear--immunology<br/>Malaria Vaccines--administration & dosage<br/>Malaria, Falciparum--prevention & control<br/>Male<br/>Membrane Proteins--genetics<br/>Middle Aged<br/>Plasmodium falciparum--genetics<br/>Protozoan Proteins--genetics<br/>Vaccines, Synthetic--administration & dosage<br/>Young Adult